LINP1 knock-down promoted doxorubicin-induced apoptosis in TNBC cell lines, while overexpression of LINP1 in an estrogen-receptor positive breast cancer cell line with untraceable LINP1 inhibited the apoptotic effects of doxorubicin in these cells. This evidence concerns the gene LINP1 and breast cancer.